Current Investments
MerLion Pharmaceuticals Pte Ltd.
Tony Buss, Singapore
Merlion Pharmaceuticals maintains one of the word's largest and most diverse collections of natural product samples, and has an antiinfective compound in early clinical development.
Merus Biopharmaceuticals BV
Ton Logtenberg, Utrecht, NL
Merus is a drug discovery company leveraging proprietary antibody platforms directed to generation and production of multiple monoclonal antibodies (termed Oligoclonics) and bi-specific antibodies (termed Biclonics) from a single cell line. The technology platform leverages fixed VL chains to produce functional monoclonal and bi-specific antibodies in a single cell. Merus’ lead programs are Oligoclonic products.
MicroCHIPS Inc.
John T. Santini, Bedford MA, US
MicroCHIPS, Inc. develops devices for the controlled release of drugs and the elective exposure of biosensors using its patented reservoir array technologies.